AAI Clinical Immunology Committee: Translational Research Toward Putting the Immune System to Sleep in Human Disease
Robert L. Modlin, University of California, Los Angeles, Chair, AAI Clinical Immunology Committee
Agnes M. Azimzadeh, University of Maryland
Fred D. Finkelman, University of Cincinnati College of Medicine, Rapid suppression of IgE-mediated allergy
Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai Medical Center, A paradigm shift in the pathogenesis and treatment of atopic dermatitis
Gerald T. Nepom, Benaroya Research Institute, Targeting effector memory in pursuit of immune tolerance
Stephen D. Miller, Northwestern University Medical School, From bench to bedside: translation of a novel nanoparticle approach for tolerogenic therapy of immune-mediated diseases
Advances in translational immunology research have led to new tactics to dampen inappropriate or excessive immune responses as therapeutic approaches for autoimmune and inflammatory diseases. This session will include discussion of present approaches and future directions that will be valuable to immunologists interested in translational research.